Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Antal Bajor"'
Autor:
Svein Oskar Frigstad, Anne Haaber, Antal Bajor, Jan Fallingborg, Per Hammarlund, Ole K. Bonderup, Håkan Blom, Terje Rannem, Per M. Hellström
Publikováno v:
Gastroenterology Research and Practice, Vol 2017 (2017)
Background. Intravenous iron allows for efficient and well-tolerated treatment in iron deficiency and is routinely used in diseases of the gastrointestinal tract. Objective. The aims of this study were to determine the probability of relapse of iron
Externí odkaz:
https://doaj.org/article/00d16cf17d424726b1cd9019a6846e4d
Autor:
Kjell-Arne Ung, Richard N. Appleby, P-G Gillberg, Hans Graffner, Magnus Simren, Antal Bajor, Jrf Walters
Publikováno v:
United European Gastroenterology Journal. 5:380-388
Background: Primary bile acid diarrhoea (BAD) is associated with increased bile acid synthesis and low fibroblast growth factor 19 (FGF19). Bile acid sequestrants are used as therapy, but are poorly tolerated and may exacerbate FGF19 deficiency. Aim:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b26d04650d4dca8e433d97c850da26b2
https://doi.org/10.1177/2050640616662432
https://doi.org/10.1177/2050640616662432
Autor:
Olof Grip, J. Torp, Ulrika L. Fagerberg, Robert Löfberg, Leif Angelison, Jonas Björk, Erik Hertervig, Mari Thörn, Henrik Hjortswang, Sven Almer, Antal Bajor, Jan Marsal, Ulf Hindorf, Pontus Karling, Jonas Halfvarson, Anders Eriksson, Per Hammarlund
Publikováno v:
Alimentary Pharmacology & Therapeutics. 45:519-532
Background Real-life long-term data on infliximab treatment in ulcerative colitis are limited. Aim To study the long-term efficacy and safety of infliximab in chronic active ulcerative colitis and ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::354625ce02f676c7955b10c2624a29d0
https://doi.org/10.1111/apt.13893
https://doi.org/10.1111/apt.13893
Autor:
Maria K. Magnusson, Kjell-Arne Ung, Antal Bajor, Anders Lasson, Lena Öhman, Hans Strid, Maria Sapnara
Publikováno v:
Journal of Crohn's and Colitis. 10:943-952
Anti-tumour necrosis factor [TNF] therapy is used in patients with ulcerative colitis [UC], but not all patients respond to treatment. Antimicrobial peptides [AMPs] and the gut microbiota are essential for gut homeostasis and may be important for tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3189c510bd69003ae24f357c0e507bb5
https://doi.org/10.1093/ecco-jcc/jjw051
https://doi.org/10.1093/ecco-jcc/jjw051
Autor:
Antal Bajor, Magnus Simren, Hasse Abrahamsson, Anders Kilander, Riadh Sadik, Per-Ove Stotzer, Henrik Sjövall
Publikováno v:
United European Gastroenterology Journal. 3:381-386
The classical definition of chronic diarrhoea is ≥3 defecations/day, with a stool weight of more than 200 g and duration of ≥4 weeks. However, with this definition many patients with substantial symptoms and pathology will be excluded from furthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c190be29e829be9e608bebfdd3b3fa
https://doi.org/10.1177/2050640615580219
https://doi.org/10.1177/2050640615580219
Autor:
Håkan Blom, Terje Rannem, Svein Oskar Frigstad, Ole K. Bonderup, Antal Bajor, Per M. Hellström, Per Hammarlund, Anne Haaber, Jan Fallingborg
Publikováno v:
Frigstad, S O, Haaber, A, Bajor, A, Fallingborg, J, Hammarlund, P, Bonderup, O K, Blom, H, Rannem, T & Hellström, P M 2017, ' The NIMO Scandinavian Study : A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency ', Gastroenterology Research and Practice, vol. 2017, 4585164 . https://doi.org/10.1155/2017/4585164
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2017 (2017)
Frigstad, S O, Haaber, A, Bajor, A, Fallingborg, J, Hammarlund, P, Bonderup, O K, Blom, H, Rannem, T & Hellstrom, P M 2017, ' The NIMO Scandinavian Study : A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency ', Gastroenterology Research and Practice, vol. 2017, 4585164 . https://doi.org/10.1155/2017/4585164
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2017 (2017)
Frigstad, S O, Haaber, A, Bajor, A, Fallingborg, J, Hammarlund, P, Bonderup, O K, Blom, H, Rannem, T & Hellstrom, P M 2017, ' The NIMO Scandinavian Study : A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency ', Gastroenterology Research and Practice, vol. 2017, 4585164 . https://doi.org/10.1155/2017/4585164
Background. Intravenous iron allows for efficient and well-tolerated treatment in iron deficiency and is routinely used in diseases of the gastrointestinal tract. Objective. The aims of this study were to determine the probability of relapse of iron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690de853cd051c2ea36e1cd2bfde2b46
https://curis.ku.dk/portal/da/publications/the-nimo-scandinavian-study(0787b9fc-7d79-43f1-bbd7-e5bb8ef4bb6b).html
https://curis.ku.dk/portal/da/publications/the-nimo-scandinavian-study(0787b9fc-7d79-43f1-bbd7-e5bb8ef4bb6b).html
Autor:
Kjell-Arne Ung, Anders Lasson, Stefan Isaksson, Maria K. Magnusson, Hans Strid, Antal Bajor, Lena Öhman
Publikováno v:
Journal of Crohn's and Colitis. 9:56-65
Background and aims: The cellular mechanisms leading to infliximab therapy response in patients with ulcerative colitis (UC) are incompletely known. We therefore investigated early effects of infliximab therapy on monocytes and associated chemokines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a605e29c3e51bdc879ad812265b474
https://doi.org/10.1093/ecco-jcc/jju008
https://doi.org/10.1093/ecco-jcc/jju008
Autor:
Per Hammarlund, Ragnar Befrits, Håkan Blom, Antal Bajor, Ola Wikman, Daniel Klintman, Lars Blomquist, Henrik Hjortswang
Publikováno v:
Scandinavian Journal of Gastroenterology. 48:1027-1032
Iron deficiency and anemia are being increasingly recognized as a complication of inflammatory bowel disease (IBD). The aim of this study was to observe, in a non-interventional way, how Swedish gastroenterologists adhere to guidelines in IBD outpati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968d2bb0f5ba7d5cf3d893fa05785f89
https://doi.org/10.3109/00365521.2013.819442
https://doi.org/10.3109/00365521.2013.819442
Autor:
Olafur S. Palsson, William E. Whitehead, Hans Törnblom, Antal Bajor, Magnus Simren, Steve Heymen
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 29(2)
Background Fecal incontinence (FI) is a prevalent but poorly recognized problem in the general population with profound negative effects on daily life. The prevalence of FI in irritable bowel syndrome (IBS) and its association with clinical, demograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89965a7982a8f5e8cf6af0ccdcf6f6d1
https://pubmed.ncbi.nlm.nih.gov/27581702
https://pubmed.ncbi.nlm.nih.gov/27581702
Publikováno v:
Alimentary Pharmacology & Therapeutics. 34:41-50
Aliment Pharmacol Ther 2011; 34: 41–50 Summary Background One half of patients with constipation are not satisfied with available therapies, hence there is a need for more effective and well-tolerated drugs. Aim To evaluate the effects of a specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70cdf76109dc3c345e839de78d5b169f
https://doi.org/10.1111/j.1365-2036.2011.04675.x
https://doi.org/10.1111/j.1365-2036.2011.04675.x